Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cardinal making $2.4 bil. move into contract drug manufacturing with R.P. Scherer buy.

This article was originally published in The Tan Sheet

Executive Summary

SCHERER IS CARDINAL ENTRY INTO CONTRACT MANUFACTURING with the wholesaler's addition of 19 production facilities in 12 countries through the $2.4 bil. acquisition of the drug delivery system developer and contract manufacturer R.P. Scherer announced May 18. The agreement will significantly expand Cardinal Health's fledgling contract manufacturing business developed through its PCI and National PharmPak repackaging operations.
Advertisement

Related Content

Cardinal Adding "Blow-Fill-Seal" Technology With $390 Mil. ALP Purchase
Cardinal Adding "Blow-Fill-Seal" Technology With $390 Mil. ALP Purchase
Cardinal Adding "Blow-Fill-Seal" Technology With $390 Mil. ALP Purchase

Topics

Advertisement
UsernamePublicRestriction

Register

PS088460

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel